摘要
儿茶酚抑素(CST),嗜铬颗粒蛋白A(CgA)衍生的阳离子和疏水多肽,首次被认为是儿茶酚胺分泌的内源性抑制剂,启肾上腺交感神经嗜铬系统的生理阻断作用。它的广泛的活性包括相关多级心血管及抗高血压作用。在中枢系统水平,CST似乎可能作用于孤束核的压力感受器传入纤维来调节心血管自主控制。这些临床和实验(CgA-KO小鼠)证据表明了CST在原发性高血压决策和预防方面的重要作用。在器官水平上,当β肾上腺素(ISO)刺激均衡化时,CST通过β2肾上腺素受体(AR)-Gi/O蛋白-一氧化氮(NO)-cGMP信号通路来发挥心肌(负性收缩力和舒张力)作用和有效地舒张内皮素-1(ET-1)-预收缩冠状动脉。心肌收缩作用已经在鱼和两栖动物的心脏上进行了深入分析,强调了多种精细的作用机制。CST也通过NO-依赖性机制影响再灌注性损伤抢救激酶(RISK)信号和激活mitoKATP通道来作为前处理和后处理的心肌保护剂。随着葡萄糖和类脂物代谢中的血管生成基因的作用和调节效应,CST引起的强心和增强冠状血管的影响,有助于描绘一个现代化综合的缩氨酸图片,这个缩氨酸作为一种具有广泛的细胞激素样特征的多效性激素出现。这篇综述的目的在于联锁一些旧的和最近的证据,可能有助于更好地感知那些仍然需要解决的难题中微妙的联系和差异。
关键词: 心肌保护,嗜铬颗粒蛋白A,心肌功能,信号传导,脊椎动物心脏
Current Medicinal Chemistry
Title:Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces
Volume: 22 Issue: 3
Author(s): R. Mazza, B. Tota and A. Gattuso
Affiliation:
关键词: 心肌保护,嗜铬颗粒蛋白A,心肌功能,信号传导,脊椎动物心脏
摘要: Catestatin (CST), the Chromogranin A (CgA)-derived cationic and hydrophobic peptide, firstly recognized as an endogenous inhibitor of catecholamine secretion, functions as a physiological brake of the adreno-sympathetic-chromaffin system. Its wide spectrum of activities includes relevant multilevel cardiovascular and antihypertensive influences. At central systemic level, CST seems to modulate the autonomic cardiovascular control possibly acting on baroreceptor afferent fibers of the nucleus tractus solitarius. This, as well as clinical and experimental (CgA-KO mice) evidences point to an important role of CST in the determinism and prevention of essential hypertension. At organ level, CST exerts myocardial (negative inotropy and lusitropy) effects and potently vasodilates endothelin-1 (ET-1)–preconstricted coronaries through β2-adrenergic receptor (AR)-Gi/o protein-nitric oxide (NO)-cGMP signalling, while counterbalancing β adrenergic (ISO) stimulation. The contractile myocardial effects have been deeply analysed in fish and amphibian hearts, highlighting finely diversified mechanisms of action. CST also acts as cardioprotective agent in both pre- and post-conditioning through NO-dependent mechanisms implicating the Reperfusion Injury Salvage Kinase (RISK) signalling and the activation of mitoKATP channels. The CST-elicited cardiotropic and coronarotropic influences, along with the recently discovered proangiogenic and regulatory effects in glucose and lipid metabolism, contribute to delineate an integrated and updated picture of the peptide which emerges as a pleiotropic hormone with a wide range of cytokine-like characteristics. The aim of this review is to interlock some older and more recent evidences which may help to better perceive the subtle links and differences among the puzzle pieces that still need to be deciphered.
Export Options
About this article
Cite this article as:
Mazza R., Tota B. and Gattuso A., Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces, Current Medicinal Chemistry 2015; 22 (3) . https://dx.doi.org/10.2174/0929867321666141106114928
DOI https://dx.doi.org/10.2174/0929867321666141106114928 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs in Organogenesis and Disease
Current Molecular Medicine Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Early Occurrence Cases of Diabetes Mellitus: Clinical Picture in Two Major Tertiary Care Hospitals in India
Current Diabetes Reviews Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Antiangiogenic Therapy in Malignant Glioma: Promise and Challenge
Current Pharmaceutical Design Diabetic Cardiomyopathy: Clinical and Metabolic Approach
Current Vascular Pharmacology Modulation of Cardiac Metabolism During Myocardial Ischemia
Current Pharmaceutical Design Editorial: [Hot Topic: Chromogranin A at the Crossroads of Health and Disease]
Current Medicinal Chemistry Sirtuins: Novel Players in Male Reproductive Health
Current Medicinal Chemistry Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters G Protein-Coupled Receptor Kinase 2 - a Feedback Regulator of Gq Pathway Signalling
Current Drug Targets - Immune, Endocrine & Metabolic Disorders MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress
Current Neurovascular Research Pure Polyphenols Applications for Cardiac Health and Disease
Current Pharmaceutical Design Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Editorial [Hot Topic:The Metabolic Treatment of Coronary Artery Disease and Heart Failure(Executive Editor: Pericle Di Napoli)]
Current Pharmaceutical Design Bioinformatics Tools for Mass Spectrometry-Based High-Throughput Quantitative Proteomics Platforms
Current Proteomics Chlorogenic Acid Suppresses a Cell Adhesion Molecule in Experimental Autoimmune Myocarditis in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Palliative Care Approach to the Advanced Heart Failure Patient
Current Cardiology Reviews Combined Anticancer Therapies: An Overview of the Latest Applications
Anti-Cancer Agents in Medicinal Chemistry